HDAC9 and acute myeloid leukemia: Independent observations have shown that hematopoietic stem cells (HSC), through the accumulation of successive mutations, develop into CSCs that expand into acute myeloid leukemia (AML) [103] and that this expansion can be inhibited by valproic acid and other HDAC inhibitors [104].